Cipzamist 137 μg & 50 μg Nasal Spray
PDF Leaflet Revision Date: Not applicable.
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of allergic rhinitis and rhino-conjunctivitis.
Dosage (summary)
One actuation in each nostril twice daily for adults and children 6 years and older.
Onset of Action / Duration
Onset: 15 mins, Duration: Long-term use recommended.
Special Populations
- Elderly patients
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Limited data; caution advised during pregnancy and breastfeeding.
Key Drug Interactions
- Ritonavir
- Ketoconazole
- Alcohol
Contraindications
- Hypersensitivity to azelastine or fluticasone
Common side effects
- Dysgeusia
- Epistaxis
- Headache
Counselling Points
- Avoid contact with eyes
- Monitor for nasal irritation
- Caution with CNS depressants
Serious warnings
- Somnolence
- Potential for glaucoma and cataracts
- Immunosuppression risk
Important Disclaimer
The Cipzamist 137 μg & 50 μg Nasal Spray professional information leaflet below is the property of Cipla Medpro and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
